Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Arnoulet

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Hematology and Cell Therapy|December 13, 1997
Immune reconstitution after blood cell transplantationA Charbonnier, D Sainty, C Faucher, et al.
Leukemia|February 24, 2001
Fine characterization of childhood and adult acute lymphoblastic leukemia (ALL) by a proB and preB surrogate light chain-specific mAb and a proposal for a new B cell ALL classificationB Lemmers, C Arnoulet, C Fossat, et al.
Acta Haematologica|July 21, 2001
Detection of epithelial cells in hematopoietic organs of patients with breast cancer. Physiopathological significance and clinical consequencesC Chabannon, S Olivero, F Viret, et al.
Leukemia|October 12, 1999
The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitorsR Costello, F Mallet, H Chambost, et al.
Cancer Research|September 2, 2000
Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacitiesR T Costello, F Mallet, B Gaugler, et al.
Leukemia|January 19, 2000
Acute myeloid leukaemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allogenic or autologous leukemic targetsR T Costello, F Mallet, H Chambost, et al.
Clinical and Laboratory Haematology|August 8, 2001
A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytesU Oelschlaegel, I Besson, C Arnoulet, et al.
Hematology and Cell Therapy|May 27, 1999
Remote tumor cells in the case of breast cancers: significance of their presence for prognosis [corrected]L Edelman, J C Durand, J P Lotz, et al.
British Journal of Haematology|April 1, 1996
Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administrationA M Stoppa, N Vey, D Sainty, et al.
Leukemia & Lymphoma|June 1, 1995
Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapyF Eberlé, Y Toiron, J Camerlo, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Hematology and Cell Therapy|December 13, 1997
Immune reconstitution after blood cell transplantationA Charbonnier, D Sainty, C Faucher, et al.
Leukemia|February 24, 2001
Fine characterization of childhood and adult acute lymphoblastic leukemia (ALL) by a proB and preB surrogate light chain-specific mAb and a proposal for a new B cell ALL classificationB Lemmers, C Arnoulet, C Fossat, et al.
Acta Haematologica|July 21, 2001
Detection of epithelial cells in hematopoietic organs of patients with breast cancer. Physiopathological significance and clinical consequencesC Chabannon, S Olivero, F Viret, et al.
Leukemia|October 12, 1999
The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitorsR Costello, F Mallet, H Chambost, et al.
Cancer Research|September 2, 2000
Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacitiesR T Costello, F Mallet, B Gaugler, et al.
Leukemia|January 19, 2000
Acute myeloid leukaemia triggering via CD40 induces leukocyte chemoattraction and cytotoxicity against allogenic or autologous leukemic targetsR T Costello, F Mallet, H Chambost, et al.
Clinical and Laboratory Haematology|August 8, 2001
A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytesU Oelschlaegel, I Besson, C Arnoulet, et al.
Hematology and Cell Therapy|May 27, 1999
Remote tumor cells in the case of breast cancers: significance of their presence for prognosis [corrected]L Edelman, J C Durand, J P Lotz, et al.
British Journal of Haematology|April 1, 1996
Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administrationA M Stoppa, N Vey, D Sainty, et al.
Leukemia & Lymphoma|June 1, 1995
Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapyF Eberlé, Y Toiron, J Camerlo, et al.
Pageof 4